Considering the fatal human victims and economic loss caused by influenza virus infection every year, methodologies for rapid and on-site detection of influenza viruses are urgently needed. LAMP is ...

Multiplex qPCR is a popular area of interest for many assay developers. Thanks to distinct reporter dyes, multiple reactions can be combined into a single well, with each target detected independently ...

Chromosomal instability (CIN) is a hallmark of distinct subclasses of tumours with potential clinical relevance. The aim of our study was to establish a time and cost effective method for the ...

The measurement of specific molecules in serum and plasma is essential in the diagnosis, treatment and management of many diseases. Traditional methods have used single assay techniques, whereby only ...

Assay developers in biopharma and research labs strive to save time, reduce costs, and ensure accurate and reproducible results. In quantitative PCR (qPCR) assays, multiplexing—the simultaneous ...

The tumor microenvironment is a complex mix of cancer cells, immune cells, and other components that all play a part in tumor progression, metastasis, and therapy responses. Understanding the highly ...

The immunoassay—a mainstay of life sciences and clinical diagnostic laboratories—detects and quantifies proteins and other kinds of molecules in complex samples, usually through the use of antibodies.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ultivue, a leading developer of tissue biomarker identification and quantification assays for translational research and pathology labs, today announced the ...

Antibody assays are widely used in clinical diagnostics and also in the process of drug development. Gold standard assay techniques include the enzyme-linked immunosorbent assay (ELISA), western ...

At virtually every stage of the processes required to bring a new drug to market—from early discovery through clinical trials—biopharma scientists would like more information. More insight into the ...

Increasing adoption of multiplexing technologies across clinical diagnostics, pharmaceutical and biotech research, academic research, and CRO environments is accelerating the evolution of ...